digital currency etf canada snippets

The Israeli army has launched more than 350 attacks in Syria. According to the news of Syrian Human Rights Watch on December 11th, local time, up to now, Israel has launched more than 352 attacks in Syria, destroying military facilities in 13 provinces in Syria. On the 10th local time, the Israel Defense Forces issued a statement saying that up to now, the Israeli military has cracked down on 320 strategic targets in Syria and destroyed weapons that may fall into the hands of hostile forces. According to Israeli military estimates, more than 70% of Syria's military forces have been destroyed.KBW upgraded Societe Generale to outperform the broader market with a target price of 32 euros.According to the Islamic Republic of Iran News Agency (IRNA), a senior Russian parliamentarian called for Iran to join the Ji 'an organization.

Grant Thornton Group, a Hong Kong financial consulting and IPO sponsor service provider, is priced at $ 4-5 per share, and plans to raise $10 million.According to the data released by Shanghai Steel Union, the price of battery-grade lithium carbonate (in early trading) was the same as that of the previous day, with an average price of 76,450 yuan/ton.Shell Tianjin Investment Co., Ltd. increased its capital to 600 million US dollars. Tianyancha App shows that recently, Shell Tianjin Investment Co., Ltd. has undergone industrial and commercial changes, and its registered capital has increased from 550 million US dollars to 600 million US dollars. The company was established in September 2018, and its legal representative is Peng Yongdong, which is wholly owned by Hongkong Enjoying International Limited.

Jiangsu Guoxin: Guoxin Bindian's 1000MW unit was officially put into production. Jiangsu Guoxin announced that a 1000MW secondary reheat ultra-supercritical coal-fired generator set newly built by its holding subsidiary Guoxin Bindian completed its 168-hour full-load trial operation and was officially put into operation on December 11, 2024.Huize released its Q3 results in 2024, and the number of insured customers exceeded 10 million. On December 10th, HUIZ.US, an insurance e-commerce service platform, released its unaudited Q3 results report in the third quarter of 2024 (hereinafter referred to as "Q3") before the opening of the US stock market. The data shows that during Q3, Huixuan contributed a total premium of 2.06 billion yuan (RMB, the same below), a total revenue of 370 million yuan and a net profit of 18.7 million yuan. After experiencing rapid growth since the reform and opening up, China's economy is entering a new normal of medium-speed development. In 2024, opportunities and challenges coexist in the insurance industry. Q3 financial report data shows that Huixuan's accumulated insured customers have exceeded 10 million.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.